JPRN-UMIN000001132已完成2 期
Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group - Docetaxel,Cisplatin versus Carboplatin,weekly Paclitaxel for patients with advanced non-small cell lung cancer : a prospective randomized phase II study of the Niigata Lung Cancer Treatment Group
iigata Lung Cancer Treatment Group0 个研究点目标入组 80 人开始时间: 2008年4月28日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
A
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded if they had any active concomitant malignancies,infections, symptomatic brain metastases, past history of severe allergic reactions to drugs, interstitial pneumonia identified by chest X-ray, superior vena cava syndrome, or other serious complications, such as uncontrolled angina pectoris, myocardial infarction within 6 months,uncontrolled diabetes mellitus or hypertension, uncontrolled massive pleural effusion or ascites.
研究者
相似试验
已完成
不适用
Docetaxel and Carboplatin once every 3 weeks versus weekly Docetaxel in advanced non-small cell lung cancer: a Multicenter phase III study from the Dutch Chest Physician Association.on small cell lung cancer (NSCLC)NL-OMON28184MCGDepartment Pulmonary Diseases440
已完成
2 期
Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)on-small sell lung carcinoma (NSCLC)JPRN-C000000310The Tokyo cooperative oncology group150
进行中（未招募）
不适用
Weekly therapy with Carboplatin and Docetaxel in patients with head-neck cancer with important comorbidity (ancer patients with chronic cardiac or circulatory disorders, people who have had cardiovascular accidents in the past, people with renal failure, etc.).Patients with head and neck cancer having high comorbidityMedDRA version: 14.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-003509-65-ITISTITUTO ONCOLOGICO VENETO
已完成
3 期
Carboplatin plus nab-Paclitaxel versus docetaxel for elderly squamous non-small cell lung cancer (CAPITAL study)Eldery patients with advanced squamous non-small-cell lung cancerJPRN-UMIN000019843ational Hospital Organization Nagoya Medical Center250
招募中
3 期
To Compare Carboplatin/ Paclitaxel with Cisplatin/ Etoposide in advanced Non Small Cell Lung cancer (NSCLC).CTRI/2020/03/023770Tata Memorial Hospital